http://www.theheart.org/conferences/acc/2012.do
近年、late-breaking clinical trials [LBCTs] だらけの様相は変わらず・・・
http://circ.ebm-library.jp/conferences/trial_ACC_2012.html
ACC.12 App (IOS、 android OS )
http://ep60.eventpilotadmin.com/appinfo.php?page=Now&project=ACC12
・ TRA 2°P TIMI-50 trial : protease-activated receptor 1 (PAR-1) antagonist antiplatelet agent vorapaxar
・ PARTNER cohort A : transcatheter valve implantation (TAVI) using the Sapien (Edwards Lifesciences) valve
・ FOCUS Study : Intramyocardial Injection of Autologous Bone Marrow Mononuclear Cells Under Electromechanical Guidance
・ C-PORT E trial : 無on-site心臓外科での待機的血管形成・ステント植え込み
・ INFUSE AMI : STEMIでの血栓吸引治療
・ HOST-ASSURE : triple antiplatelet therapy 及び drug-eluting stent
・ BRIDGE-ACS : 急性冠症候群でのtreatment-gap analysis
・ EINSTEIN PE : new rivaroxaban (Xarelto, Bayer/Johnson & Johnson) data
・ CORONARY : comparing on- and off-pump CABG
・ ACRIN PA 4005 : ACS疑診例でのCT coronary angiographyの役割
・ ROMICAT II : 心CTでの心筋梗塞除外多施設研究
・ REGN727/SAR236553 (Regeneron/Sanofi)
・ STAMPEDE : 2型糖尿病:積極内服治療+bariatric surgery
・ American College of Cardiology Foundation/ Society of Thoracic Surgeons (ACCF-STS) 、ASCERT データベース 高リスク PCI vs CABG比較 (STS 2012 meeting発表済み)
・ IMMEDIATE trial : glucose, insulin, and potassium (GIK) in ACS
・ MOPETT : looking at the use of alteplase (Activase, Genentech) moderate pulmonary embolism.
0 件のコメント:
コメントを投稿